Log in

OTCMKTS:CLPBYCOLOPLAST A/S/ADR Stock Price, Forecast & News

$14.31
-0.35 (-2.39 %)
(As of 04/9/2020 03:15 AM ET)
Add
Compare
Today's Range
$14.15
Now: $14.31
$14.47
50-Day Range
$12.31
MA: $13.70
$14.99
52-Week Range
$9.90
Now: $14.31
$15.15
Volume60,204 shs
Average Volume64,400 shs
Market Capitalization$30.91 billion
P/E Ratio51.11
Dividend Yield1.54%
Beta0.22
Coloplast A/S develops and markets intimate healthcare products and services worldwide. The company operates through three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit to individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as SpeediCath catheters that offer catherisation for both genders; Peristeen, an anal irrigation system for controlled emptying of the bowels; and Conveen Active urine bags. In addition, it provides wound care products, such as foam dressings under the Biatain brand and hydrocolloid dressing under the Comfeel brand, as well as skin care products, such as bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. It offers disposable products that include prostate catheters and stents used before, during, and after surgery under the Porgès brand; vaginal slings to restore continence; synthetic mesh products to treat weak pelvic floor; and penile implants for men. The company supplies its products to hospitals, institutions, wholesalers, and pharmacies; and directly to users. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Read More
COLOPLAST A/S/ADR logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 3.3Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.25 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:CLPBY
Previous SymbolNASDAQ:CLPBY
CUSIPN/A
CIKN/A
Phone45-4911-1111

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.76 billion
Cash Flow$0.28 per share
Book Value$0.48 per share

Profitability

Net Income$585.21 million

Miscellaneous

Employees12,234
Outstanding Shares2,160,000,000
Market Cap$30.91 billion
Next Earnings Date5/7/2020 (Estimated)
OptionableNot Optionable

Receive CLPBY News and Ratings via Email

Sign-up to receive the latest news and ratings for CLPBY and its competitors with MarketBeat's FREE daily newsletter.


COLOPLAST A/S/ADR (OTCMKTS:CLPBY) Frequently Asked Questions

How has COLOPLAST A/S/ADR's stock been impacted by COVID-19 (Coronavirus)?

COLOPLAST A/S/ADR's stock was trading at $13.5590 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CLPBY stock has increased by 5.5% and is now trading at $14.31. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of COLOPLAST A/S/ADR?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for COLOPLAST A/S/ADR in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for COLOPLAST A/S/ADR.

When is COLOPLAST A/S/ADR's next earnings date?

COLOPLAST A/S/ADR is scheduled to release its next quarterly earnings announcement on Thursday, May 7th 2020. View our earnings forecast for COLOPLAST A/S/ADR.

How were COLOPLAST A/S/ADR's earnings last quarter?

COLOPLAST A/S/ADR (OTCMKTS:CLPBY) announced its quarterly earnings results on Thursday, May, 2nd. The company reported $0.07 EPS for the quarter, hitting the consensus estimate of $0.07. The company had revenue of $688.45 million for the quarter. COLOPLAST A/S/ADR had a net margin of 21.62% and a return on equity of 69.30%. View COLOPLAST A/S/ADR's earnings history.

What guidance has COLOPLAST A/S/ADR issued on next quarter's earnings?

COLOPLAST A/S/ADR updated its FY 2020 Pre-Market earnings guidance on Thursday, February, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $19.19473-19.37412 billion.

Has COLOPLAST A/S/ADR been receiving favorable news coverage?

Media stories about CLPBY stock have trended very negative this week, according to InfoTrie Sentiment. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. COLOPLAST A/S/ADR earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutCOLOPLAST A/S/ADR.

Who are some of COLOPLAST A/S/ADR's key competitors?

What other stocks do shareholders of COLOPLAST A/S/ADR own?

Based on aggregate information from My MarketBeat watchlists, some companies that other COLOPLAST A/S/ADR investors own include Advanced Micro Devices (AMD), Broadcom (AVGO), Exelixis (EXEL), Aimmune Therapeutics (AIMT), Baidu (BIDU), GW Pharmaceuticals PLC- (GWPH), Intuitive Surgical (ISRG), Kala Pharmaceuticals (KALA), Intellia Therapeutics (NTLA) and NVIDIA (NVDA).

Who are COLOPLAST A/S/ADR's key executives?

COLOPLAST A/S/ADR's management team includes the following people:
  • Mr. Kristian Villumsen, Pres & CEO (Age 49)
  • Mr. Anders Lonning-Skovgaard, Exec. VP & CFO (Age 47)
  • Mr. Allan Rasmussen, Exec. VP of Global Operations (Age 52)
  • Ellen Bjurgert, VP of Investor Relations
  • Lina Danstrup, Sr. Media Relations Mang. of Corp. Communications

What is COLOPLAST A/S/ADR's stock symbol?

COLOPLAST A/S/ADR trades on the OTCMKTS under the ticker symbol "CLPBY."

How do I buy shares of COLOPLAST A/S/ADR?

Shares of CLPBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is COLOPLAST A/S/ADR's stock price today?

One share of CLPBY stock can currently be purchased for approximately $14.31.

How big of a company is COLOPLAST A/S/ADR?

COLOPLAST A/S/ADR has a market capitalization of $30.91 billion and generates $2.76 billion in revenue each year. The company earns $585.21 million in net income (profit) each year or $0.30 on an earnings per share basis. COLOPLAST A/S/ADR employs 12,234 workers across the globe. View additional information about COLOPLAST A/S/ADR.

What is COLOPLAST A/S/ADR's official website?

The official website for COLOPLAST A/S/ADR is http://www.coloplast.com/.

How can I contact COLOPLAST A/S/ADR?

COLOPLAST A/S/ADR's mailing address is HOLTEDAM 1-3, HUMLEBAEK G7, 3050. The company can be reached via phone at 45-4911-1111 or via email at [email protected]

This page was last updated on 4/9/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel